05:51 PM EDT, 03/17/2026 (MT Newswires) -- Akari Therapeutics ( AKTX ) said late Tuesday it will change its American depositary shares to ordinary shares ratio. One ADS will now represent 80,000 ordinary shares instead of 2,000 ordinary shares, effective March 31.

Akari said the ratio change will help it maintain compliance with the Nasdaq minimum bid price requirement for continued listing.

On March 31, each ADS holder will be required to exchange every 40 ADS for one new ADS, with Deutsche Bank facilitating the exchange of shares, the company said.

Any fractional new ADS will be aggregated and sold, with the net cash proceeds distributed to the applicable ADS holders by Deutsche Bank, according to Akari.